|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2007-1-15
|
|
pubmed:abstractText |
At present, 20-30% of patients do not respond to cardiac resynchronization therapy (CRT). In this study, the relation between the extent of viable myocardium and scar tissue vs. response to CRT was evaluated. In addition, the presence of scar tissue in the left ventricular (LV) lead position was specifically related to response to CRT.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
0195-668X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
28
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
33-41
|
|
pubmed:dateRevised |
2007-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:17121757-Aged,
pubmed-meshheading:17121757-Cardiac Pacing, Artificial,
pubmed-meshheading:17121757-Cicatrix,
pubmed-meshheading:17121757-Electrocardiography,
pubmed-meshheading:17121757-Female,
pubmed-meshheading:17121757-Heart Failure,
pubmed-meshheading:17121757-Humans,
pubmed-meshheading:17121757-Male,
pubmed-meshheading:17121757-Myocardial Ischemia,
pubmed-meshheading:17121757-Organophosphorus Compounds,
pubmed-meshheading:17121757-Organotechnetium Compounds,
pubmed-meshheading:17121757-Radiopharmaceuticals,
pubmed-meshheading:17121757-Tomography, Emission-Computed, Single-Photon,
pubmed-meshheading:17121757-Treatment Outcome,
pubmed-meshheading:17121757-Ventricular Dysfunction, Left
|
|
pubmed:year |
2007
|
|
pubmed:articleTitle |
Impact of viability and scar tissue on response to cardiac resynchronization therapy in ischaemic heart failure patients.
|
|
pubmed:affiliation |
Department of Cardiology, Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, the Netherlands.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
